Skip to content

Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With CD

Analysis of Microbial Community Characteristics in Intestinal Mucosal Tissue of Patients With Crohn's Disease

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06895772
Enrollment
50
Registered
2025-03-26
Start date
2024-11-01
Completion date
2025-12-31
Last updated
2025-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Crohn's Disease (CD)

Brief summary

The characteristics of the intestinal microbiota in Crohn's disease and their relationship with disease pathogenesis have not yet been fully elucidated. Therefore, this study aims to analyze the microbial community characteristics in the intestinal mucosal tissue of Crohn's disease patients and fill this knowledge gap. Additionally, this research holds significant importance for understanding the etiology of Crohn's disease and predicting treatment outcomes.

Interventions

None listed

Sponsors

Shandong University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients with Crohn's disease undergoing endoscopic examination * Healthy individuals with no symptoms undergoing colonoscopy without any lesions detected * Patients undergoing small intestinal endoscopy due to symptoms but with negative examination results. * Age between 18 and 80 years. * Patients or authorized family members sign the relevant informed consent forms.

Exclusion criteria

* Patients with concurrent digestive system diseases that may affect the study results, including tumors, infections, or other autoimmune diseases. * Patients with concurrent non-digestive system diseases that may affect the study results, including tumors, infections, or autoimmune diseases. * Patients who have taken probiotics or antibiotics within the past week. * Patients with psychiatric disorders or other conditions that prevent them from cooperating with the study. * Patients participating in other clinical trials that may interfere with the results of this study.

Design outcomes

Primary

MeasureTime frameDescription
The characteristics of the intestinal microbiota in Crohn's disease12 monthsAnalyze the characteristics of the microbiota within the intestinal mucosal tissue of patients with Crohn's disease;Analyze the differences in the microbiota between the lesional and normal intestinal mucosal tissues of patients with Crohn's disease;Analyze the differences in the microbiota within the intestinal mucosal tissue of patients with Crohn's disease before and after treatment.

Secondary

MeasureTime frameDescription
Contrast the characteristics of the intestinal microbiota in Crohn's disease and healthy individuals12 monthsCompare the differences in the microbiota within the intestinal mucosal tissue between patients with Crohn's disease and healthy individuals

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026